ACM
ATRC icon

Archon Capital Management’s AtriCure ATRC Stock Holding History

Archon Capital Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-124,664
Closed -$2.39M – 24
2017
Q1 		$2.39M Buy
+124,664
New +$2.18M 3.4% 13

Other funds holding ATRC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Archon Capital Management's ATRC Position: Q2 2017 in Review

Archon Capital Management sold out of AtriCure (ATRC) in Q2 2017, closing a stake of 124,664 shares — an estimated $2.39M sold.

Archon Capital Management first reported a position in ATRC in Q1 2017 and held it in 1 quarter. The position peaked at $2.39M in Q1 2017. 107 funds tracked by Wall St. Rank hold ATRC as of Q2 2017.

  • Archon Capital Management reported no remaining AtriCure position as of Q2 2017 after selling out during the quarter.
  • Archon Capital Management sold 124,664 AtriCure shares in Q2 2017, an estimated $2.39M.
  • Archon Capital Management first reported a position in AtriCure in Q1 2017 and held it in 1 quarter.
  • Archon Capital Management's AtriCure position peaked at $2.39M in Q1 2017.
  • 107 funds tracked by Wall St. Rank held AtriCure as of Q2 2017.

Based on Archon Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.